X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.cphi-online.com/cayman-chemical-receives-cep-for-latanoprost-api-news122702.html
https://www.prnewswire.com/news-releases/thea-pharma-inc-launches-iyuzeh-latanoprost-ophthalmic-solution-0-005-in-the-us-301938385.html
https://www.prnewswire.com/news-releases/iyuzeh-latanoprost-ophthalmic-solution-0-005-the-first-and-only-preservative-free-latanoprost-ophthalmic-solution-demonstrated-similar-iop-lowering-efficacy-with-a-favorable-safety-profile-when-compared-to-xalatan-in-patien-301761686.html
https://www.fiercepharma.com/pharma/thea-pharma-gets-fda-nod-preservative-free-rival-sun-and-viatris-glaucoma-eye-drops
https://www.globenewswire.com/news-release/2022/09/29/2525541/0/en/TearClear-Announces-Positive-Topline-Results-from-CLEAR-Phase-3-Study-for-the-Treatment-of-Glaucoma-with-TC-002-latanoprost-ophthalmic-solution-0-005.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-latanoprost-neutarsudil-dimesylate-1646027967.pdf
https://www.globenewswire.com/news-release/2022/02/07/2379715/0/en/TearClear-announces-the-successful-initiation-of-its-TC-002-Latanoprost-Ophthalmic-Solution-Phase-3-trial.html
https://investors.aeriepharma.com/news-releases/news-release-details/aerie-concludes-exclusive-license-agreement-santen-rhopressar
https://www.globenewswire.com/news-release/2021/07/01/2256215/0/en/Nicox-s-NCX-470-Demonstrates-Significant-Intraocular-Pressure-Lowering-in-Dolomites-Phase-2-Glaucoma-Trial.html
https://www.globenewswire.com/news-release/2021/06/25/2253001/0/en/Nicox-s-Licensee-Bausch-Lomb-Receives-Approval-for-VYZULTA-latanoprostene-bunod-ophthalmic-solution-0-024-in-the-United-Arab-Emirates.html
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-november-2020
https://www.globenewswire.com/news-release/2020/09/02/2087409/0/en/Nicox-Completes-Enrollment-of-the-Adaptive-Design-Cohort-of-NCX-470-Mont-Blanc-Phase-3-Glaucoma-Trial.html
https://www.prnewswire.com/news-releases/qbiotics-announces-first-patient-dosed-in-its-phase-iii-clinical-trial-of-tigilanol-tiglate-for-head-and-neck-cancer-300967736.html
https://www.businesswire.com/news/home/20191203005049/en/Aerie-Pharmaceuticals-Submits-Marketing-Authorisation-Application-Roclanda%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-7-2019-1565155577.pdf
https://www.thepharmaletter.com/in-brief/brief-program-to-boost-access-to-xelpros-in-usa
https://www.pharmacompass.com/pdf/news/indoco-remedies-fails-edqm-inspection-1549481534.pdf
https://www.indiainfoline.com/article/news-top-story/sun-pharma-launches-xelpros-in-us-119011200204_1.html
https://www.reuters.com/article/us-nicox-china/nicox-teams-up-with-chinese-firm-to-develop-and-sell-glaucoma-drug-idUSKBN1OG0J3
http://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-announces-early-notification-fda
http://investors.aeriepharma.com/news-releases/news-release-details/aerie-pharmaceuticals-submits-new-drug-application-us-food-and-0
https://www.pharmacompass.com/pdf/news/Imprimis-Pharmaceuticals-Receives-FDA-Warning-Letter-1516167417.pdf
http://www.pmlive.com/pharma_news/fdas_year-end_approvals_take_annual_tally_to_46_1215003
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2017-1505277974.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-19-2017-1492575710.pdf
http://www.fiercepharma.com/regulatory/indoco-injectables-plant-smacked-fda-warning-letter
http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-hits-Indoco-with-warning-due-to-leaky-glaucoma-drug
http://www.fiercepharma.com/manufacturing/valeant-indicates-bausch-plant-responsible-for-crl-now-ready-to-go
http://www.in-pharmatechnologist.com/Ingredients/Aerie-to-build-manufacturing-facility-in-Ireland
http://www.reuters.com/article/us-inotek-pharms-study-idUSKBN14N0ZS
https://www.pharmacompass.com/pdf/news/forbidden-xalacom-eye-drops-of-pfizer-1477044514.pdf
http://www.statnews.com/pharmalot/2016/03/08/patents-override-congress/
http://www.pmlive.com/pharma_news/merck_and_sun_pharma_part_company_on_branded_generics_932930
http://www.financialexpress.com/article/markets/sun-pharmaceuticals-opthalmic-biz-foray-positive/83458/
http://psdv.client.shareholder.com/releasedetail.cfm?ReleaseID=906413
http://in.reuters.com/article/2015/02/10/us-health-glaucoma-idINKBN0LE0DG20150210?feedType=RSS&feedName=health&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29
Market Place
Share 
